Georgian medical news · 2025
DISCONTINUATION OF ANTIEPILEPTIC DRUGS AFTER EMBOLIZATION OF DURAL ARTERIOVENOUS FISTULAS.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ranxha E, Kënga D, Çibuku O, Basha E, Vyshka G
Аннотация
BACKGROUND: Seizures associated with dural arteriovenous fistulas (dAVFs) are rare, and the safety of antiseizure medication (ASM) discontinuation after embolization remains uncertain.
METHODS: A retrospective review of five patients with seizure-associated dAVFs treated with embolization was conducted. Clinical and angiographic outcomes were analyzed, focusing on seizure recurrence and ASM discontinuation.
RESULTS: Three patients successfully discontinued ASMs without recurrence, while one experienced a relapse after early discontinuation. Statistical analyses showed no significant correlation between seizure-free duration and ASM discontinuation (p=0.146) or seizure type and ASM management (p=0.317).
CONCLUSION: ASM discontinuation may be feasible in selected post-embolization patients, but individualized decisions are essential. Larger studies are needed to establish guidelines for post-treatment seizure management.
METHODS: A retrospective review of five patients with seizure-associated dAVFs treated with embolization was conducted. Clinical and angiographic outcomes were analyzed, focusing on seizure recurrence and ASM discontinuation.
RESULTS: Three patients successfully discontinued ASMs without recurrence, while one experienced a relapse after early discontinuation. Statistical analyses showed no significant correlation between seizure-free duration and ASM discontinuation (p=0.146) or seizure type and ASM management (p=0.317).
CONCLUSION: ASM discontinuation may be feasible in selected post-embolization patients, but individualized decisions are essential. Larger studies are needed to establish guidelines for post-treatment seizure management.